학술논문

Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease
Document Type
Article
Source
In: Clinical Therapeutics. (Clinical Therapeutics, November 2022, 44(11):1449-1462)
Subject
Language
English
ISSN
1879114X
01492918